Home›Companies›Healthcare›Solaris Endovascular

Solaris Endovascular Inc.

Develops covered stents for patients with dialysis access problems and peripheral artery disease.

Updated Nov 9, 2026·Latest SEC filing Oct 1, 2026·Suggest an edit

About Solaris Endovascular

Solaris Endovascular is a private company based in Dallas, Texas, incorporated in 2024 in Delaware. It has reported $4,972,500 raised in one offering on Form D since October 2026. Its chief executive is Randolph Hubbell.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 5, 2025Oct 1, 2026$4,972,500of $10.0M target45$110KEquity, Debt, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Solaris Endovascular's Form D filed Oct 1, 2026.

RH
Randolph Hubbell
Chief Executive Officer and director
MN
MC
Marco Costa
Chief Scientific & Medical Officer, director
DS
David Stack
Director
MH
Matthew Head
Executive officer
Also a chief financial officer at OncoNano.

Sources

  1. SECSolaris Endovascular Inc. filing history
  2. CompanyAbout Solaris Endovascular
  3. PressSolaris Endovascular press releases